ESOU 2019: Open and Robot-Assisted Pelvic Lymphadenectomy
Prague, Czech Republic (UroToday.com) Dr. Joniau presented on open and robot-assisted pelvic lymphadenectomy for prostate cancer, with an emphasis on the feasibility and extent of extended (and super-extended) pelvic lymphadenectomy (ePLND and sePLND). His talk revolved primarily around surgical videos from a robotic PLND and an open PLND, but I will highlight some of his main take-home points below.
ESOU 2019: Conservative Management of Upper Tract Urinary Cancer
Prague, Czech Republic (UroToday.com) In this presentation on the conservative management of upper tract urothelial carcinoma (UTUC), Dr. Alberto Breda provides an overview of the current status of conservative treatment options and potential future management options.
ESOU 2019: Optimizing Functional Outcomes in Radical Cystectomy: Prostate Sparing Approaches
Prague, Czech Republic (UroToday.com) In this first talk, Dr. Sanchez-Salaz reviews options of prostate sparing approaches for optimizing functional outcomes in patients undergoing radical cystectomy.
ESOU 2019: Optimizing Functional Outcomes in Radical Cystectomy: Robotic Nerve-Sparing Radical Cystectomy
Prague, Czech Republic (UroToday.com) Dr. Joan Palou gave the second talk in this series about improving functional outcomes following radical cystectomy. The first talk was on prostate sparing radical cystectomy, while this talk focused more on robotic nerve-sparing radical cystectomy.
ESOU 2019: Optimizing Functional Outcomes in Radical Cystectomy: Open Nerve-Sparing Radical Cystectomy
Prague, Czech Republic (UroToday.com) Dr. Arnulf Stenzl gave the third talk in this series about improving functional outcomes following radical cystectomy (RC), specifically open RC. Dr. Palau had given a similar talk but for robotic RC. Dr. Stenzl did note that videos were difficult with open surgery, so he would spend more time talking about anatomy.
ESOU 2019: Final Results of the POUT Trial
Prague, Czech Republic (UroToday.com) Dr. Robert Jones, on behalf of the POUT investigators, presents the final analysis and results of the POUT trial. A Phase III Randomized Trial of Peri-Operative Chemotherapy Versus Surveillance in Upper Tract Urothelial Cancer.
He first started by setting the stage for the study. Upper tract urothelial carcinoma (UTUC) is rare when compared to bladder cancer. However, unlike bladder cancer, 60% of UTUC patients present with invasive disease. At this time, the standard of care for these patients is radical nephroureterectomy (RNU) and observation.
ESOU 2019: Treatment of Positive Pelvic Lymph Nodes: Genomics
Prague, Czech Republic (UroToday.com) The assessment of genomics as part of the treatment of men with positive lymph nodes was presented by Dr. Kristiansen from Germany. He notes that the molecular classification of localized prostate cancer is a diverse landscape but predominantly made up of TMPRSS2-ERG, TP53, PTEN, SPOP mutants, CHD1, and ETS rearrangements. In this presentation, Dr. Kristiansen briefly highlighted several of these important genes.